The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Eisele Jeffrey since 2023.
This trader's CIK number is 1827326.
At the time of last reporting, Eisele Jeffrey was the Chief Development Officer of Apellis Pharmaceuticals, Inc.. (stock ticker symbol APLS).
Also see all insider trading activities at Apellis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | APLS | 0 | $0 | 1,833 | $55,063 | 0 | $0 |
| 2024 | APLS | 0 | $0 | 15,880 | $1,026,612 | 0 | $0 |
| 2023 | APLS | 0 | $0 | 2,529 | $159,765 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-29 | APLS | Sale | 278 | 29.52 | 8,207 |
| 2025-01-22 | APLS | Sale | 1,291 | 30.43 | 39,279 |
| 2025-01-13 | APLS | Sale | 264 | 28.70 | 7,577 |
| 2024-01-29 | APLS | Sale | 279 | 64.14 | 17,894 |
| 2024-01-30 | APLS | Sale | 971 | 65.53 | 63,629 |
| 2024-01-23 | APLS | Sale | 7,378 | 63.69 | 469,904 |
| 2024-01-22 | APLS | Sale | 1,607 | 65.00 | 104,448 |
| 2024-01-17 | APLS | Sale | 5,207 | 65.58 | 341,475 |
| 2024-01-16 | APLS | Sale | 438 | 66.81 | 29,262 |
| 2023-02-23 | APLS | Sale | 1,646 | 68.76 | 113,178 |
| 2023-01-30 | APLS | Sale | 883 | 52.76 | 46,587 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eisele Jeffrey (Chief Development Officer of Apellis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.